GlassScriptPhysician profile
William John Gilchrist
NPI 1346233558
$1,735.09
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,052 · 2020: $598 · 2021: $57.90 · 2022: $26.81.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $532.29 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $357.31 | 2019-2021 | |
| Janssen Biotech, INC. | $265.67 | 2019-2021 | |
| Gilead Sciences, INC. | $104.38 | 2019-2020 | |
| Daiichi Sankyo INC. | $85.23 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.32 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $64.63 | 2019-2020 | |
| Allergan, INC. | $56.62 | 2019 | |
| Ucb, INC. | $38.49 | 2019 | |
| Pfizer INC. | $34.92 | 2019-2020 | |
| Shionogi INC | $23.62 | 2019 | |
| Nestle Healthcare Nutrition INC. | $17.28 | 2021 | |
| Pharmacosmos Therapeutics INC. | $14.62 | 2021 | |
| Qol Medical, LLC | $12.30 | 2020 | |
| Celgene Corporation | $11.96 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.55 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.00 | 2020 | |
| Endo Pharmaceuticals INC. | $10.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gilchrist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.